Assay News and Research

RSS
Identification of linear B cell epitopes in the SARS-CoV-2 proteome that are conserved in humans coronaviruses

Identification of linear B cell epitopes in the SARS-CoV-2 proteome that are conserved in humans coronaviruses

15 Mar 2022
One-step ELISA experiments

One-step ELISA experiments

From AMS Biotechnology 15 Mar 2022
Study explores SARS-CoV-2 seroprevalence among vaccinated hospital workers

Study explores SARS-CoV-2 seroprevalence among vaccinated hospital workers

14 Mar 2022
Study explores neutralization of SARS-CoV-2 Omicron variant by subunit vaccine boosters

Study explores neutralization of SARS-CoV-2 Omicron variant by subunit vaccine boosters

14 Mar 2022
Protection against SARS-CoV-2 Omicron variant by hetero-bivalent nanobodies

Protection against SARS-CoV-2 Omicron variant by hetero-bivalent nanobodies

14 Mar 2022
Factors influencing cross-protective serological immunity against SARS-CoV-2 variants in Asians

Factors influencing cross-protective serological immunity against SARS-CoV-2 variants in Asians

14 Mar 2022
Bioactive small molecules enhance CRISPR/Cas9 loss-of-function editing in human cells

Bioactive small molecules enhance CRISPR/Cas9 loss-of-function editing in human cells

14 Mar 2022
Immunobridging study shows immunogenicity in adolescents receiving SARS-CoV-2 mRNA and inactivated vaccines

Immunobridging study shows immunogenicity in adolescents receiving SARS-CoV-2 mRNA and inactivated vaccines

14 Mar 2022
Exploring SARS-CoV-2 spike evolution in relation to sensitivity to antiviral restriction factors

Exploring SARS-CoV-2 spike evolution in relation to sensitivity to antiviral restriction factors

11 Mar 2022
Aminoglycoside antibiotic geneticin shows selective antiviral effect against SARS-CoV-2

Aminoglycoside antibiotic geneticin shows selective antiviral effect against SARS-CoV-2

11 Mar 2022
Further optimization of cysteine-reactive pyrazoline-based covalent inhibitors for the SARS-CoV-2 Mpro

Further optimization of cysteine-reactive pyrazoline-based covalent inhibitors for the SARS-CoV-2 Mpro

11 Mar 2022
Natural SARS-CoV-2 infection-induced anti-spike antibody responses

Natural SARS-CoV-2 infection-induced anti-spike antibody responses

10 Mar 2022
Study finds chimeric mRNA induces potent and broadly acting neutralizing antibodies against SARS-CoV-2 variants

Study finds chimeric mRNA induces potent and broadly acting neutralizing antibodies against SARS-CoV-2 variants

10 Mar 2022
Study isolated largest panel of β-CoV broadly neutralizing antibodies to date

Study isolated largest panel of β-CoV broadly neutralizing antibodies to date

10 Mar 2022
The trajectory of B-cell immunity six months after mRNA vaccination

The trajectory of B-cell immunity six months after mRNA vaccination

10 Mar 2022
The relationship between highly conserved residues in the SARS CoV fusion peptide and their role in coordinating calcium binding for viral entry

The relationship between highly conserved residues in the SARS CoV fusion peptide and their role in coordinating calcium binding for viral entry

9 Mar 2022
A predictive model for COVID-19 outcomes

A predictive model for COVID-19 outcomes

9 Mar 2022
Viral load reduction effectiveness of SARS-CoV-2 BNT162b2 mRNA booster vaccine wanes with time

Viral load reduction effectiveness of SARS-CoV-2 BNT162b2 mRNA booster vaccine wanes with time

9 Mar 2022
Assessment of oligonucleotides as COVID-19 treatment

Assessment of oligonucleotides as COVID-19 treatment

8 Mar 2022
A new view of SARS-CoV-2 genome structure

A new view of SARS-CoV-2 genome structure

8 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback